Home > Healthcare > Medical Devices > Therapeutic Devices > Platelet Rich Plasma (PRP) Market

Platelet Rich Plasma (PRP) Market Size

Report ID: GMI10133
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Platelet Rich Plasma Market Size

Platelet Rich Plasma Market size was valued at USD 479.6 million in 2023 and is anticipated to witness growth at a CAGR of 10.6% between 2024 and 2032. The increasing prevalence of chronic and lifestyle-related diseases, such as orthopedic conditions, sports injuries, and cardiovascular diseases, has heightened the demand for advanced therapeutic options like PRP.

Platelet Rich Plasma Market

To get key market trends

Download Free Sample

Additionally, the rising number of cosmetic and aesthetic procedures, particularly in dermatology, where PRP is used for skin rejuvenation and hair loss treatments, significantly boosts market growth. Furthermore, supportive government initiatives and an increasing number of clinical trials demonstrating the efficacy and safety of PRP therapy contribute to its expanding adoption across various medical fields. The increasing demand for PRP therapy drives the growth of PRP systems market.

Platelet Rich Plasma Market Report Attributes
Report Attribute	Details
Base Year:	2023
Platelet Rich Plasma Market Size in 2023:	USD 479.6 Million
Forecast Period:	2024-2032
Forecast Period 2024-2032 CAGR:	10.6%
2032 Value Projection:	USD 1.2 Billion
Historical Data for:	2021-2023
No. of Pages:	155
Tables, Charts & Figures:	273
Segments covered:	Type, Origin, Application, End-use, and Region
Growth Drivers:	Increasing prevalence of sports injuries and orthopedic conditions Growing cosmetic and aesthetic applications Increasing awareness and acceptance of regenerative medicine
Pitfalls & Challenges:	High cost Lack of standardization

Learn more about the key segments shaping this market

Download Free Sample

Platelet Rich Plasma (PRP) systems or kits are medical devices used to prepare and administer Platelet Rich Plasma (PRP) from blood. Platelet-Rich Plasma (PRP) is a concentration of blood platelets, containing a higher number of platelets than what is typically found in blood. The PRP kits/systems are designed to separate and concentrate platelets from the patient's blood to produce PRP for therapeutic use. PRP plays a crucial role in healing and tissue regeneration by releasing growth factors that stimulate cell proliferation, tissue repair, and collagen production.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global platelet rich plasma industry was valued at USD 479.6 million in 2023 and is anticipated to register 10.6% CAGR between 2024 and 2032 due to the increasing prevalence of sports injuries and orthopedic conditions.

The pure segment in the PRP market accounted for USD 211.1 million, attributed to its extensive application in various medical and aesthetic procedures.

North America platelet rich plasma industry is anticipated to reach USD 395.4 million by 2032, driven by robust healthcare infrastructure, and high adoption rates of regenerative medicine technologies.

Arthrex Inc., APEX Biologix, Celling Biosciences, Inc., DePuy Synthes (Johnson & Johnson), Dr. PRP USA LLC, EmCyte Corporation, Exactech, Inc., Glofinn Oy, Isto Biologics, Juventix Regenerative Medical, LLC., and Regen Lab SA., among others.